JNPR
51
2
DOV
50
2
ROP
39
4
AMGN
7
-23
HIG
62
3
BF.B
28
3
FOX
53
2
NOV
34
-3
FIS
63
5
VIX
41
-6
OKE
43
-5
JBHT
30
4
FFIV
68
6
QCOM
57
2
PPL
72
7
ZTS
21
2
TROW
42
5
CNP
44
3
LRCX
65
3
RHI
13
3
JNPR
51
2
DOV
50
2
ROP
39
4
AMGN
7
-23
HIG
62
3
BF.B
28
3
FOX
53
2
NOV
34
-3
FIS
63
5
VIX
41
-6
OKE
43
-5
JBHT
30
4
FFIV
68
6
QCOM
57
2
PPL
72
7
ZTS
21
2
TROW
42
5
CNP
44
3
LRCX
65
3
RHI
13
3
Financhill
Back

Microsoft Vs. Blueprint Medicines Industry Stock Comparison

Buy
67

MSFT
Microsoft

Last Price:
$490.64
Seasonality Move:
1.98%
Sell
50

BPMC
Blueprint Medicines

Last Price:
$128.19
Seasonality Move:
10.35%
Buy
67
Microsoft (MSFT) is a Buy

Is Microsoft a Buy, Sell or Hold?

  • The current Microsoft [MSFT] share price is $486.00. The Score for MSFT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • MSFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.40. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MSFT Stock Price Chart

What is Microsoft's stock price today?

  • The Microsoft share price today is $486.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSFT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.68 Buy
Relative Strength Index (14 RSI): 74.1 Buy
Chaikin Money Flow: 19153727 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (456.66 - 476.44) Buy
Bollinger Bands (100): (380.46 - 451.9) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.37 Buy
Relative Strength Index (14 RSI): 75.84 Buy
Chaikin Money Flow: 2405267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.82 - 130.54) Buy
Bollinger Bands (100): (84.96 - 114.18) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 478.41 Buy
20-day SMA: 469.25 Buy
50-day SMA: 437.03 Buy
200-day SMA: 421.25 Buy
8-day EMA: 478.22 Buy
20-day EMA: 468.84 Buy
50-day EMA: 446.51 Buy
200-day EMA: 422.03 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.17 Buy
20-day SMA: 121.09 Buy
50-day SMA: 104.25 Buy
200-day SMA: 96.1 Buy
8-day EMA: 127.55 Buy
20-day EMA: 121.54 Buy
50-day EMA: 110.11 Buy
200-day EMA: 98.48 Buy

Microsoft Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.71 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Microsoft Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):